Additional SAOs Which Are Not Included on Dun & Bradstreet List

The following companies meet the definition of 'substantially affected organizations' (SAO) even though they are not identified as such on the Dun & Bradstreet (D&B) listing (see List of SAOs and description of how SAOs are identified).

If an IC Ethics Official identifies a questionable entity and suggests inclusion on the SAO list, send sufficient information about the entity, including rationale for why it should be considered an SAO, to your assigned NEO Specialist for a determination. Confirmed entities will be added to this list. If an entity has additional information available, the name is linked to the other information.

Format: Entity Name (Date added to list - Month/Year)

AbbVie (3/13)

Medtronics (8/11)

Acordia Therapeutics, Inc. (6/14)

Merus Labs International (Norgine BV) (MSLI) (12/18)

Acceleron Pharma (11/18)

MilliporeSigma (formerly known as EMD Millipore) (7/19)

Affymetrix (11/06)

Mindray Medical International Ltd (7/09)

Allakos, Inc (11/18)

MST Medical Surgery Technologies, Inc. (8/13)

Anacore Pharmaceuticals, Inc. (6/14)

Neogenomics, Inc. (NEO) (3/20)

argenx SE (ARGX) (5/20)

ObsEva SA (OBSV) (4/20)

Avita Medical Limited (2/20)

Pacific Biosciences (4/13)

Baxalta, Inc (Shire Plc) (12/18)

Photovac (4/06)

Bayer Aktiengesellschaft (8/19)

Portilla Pharmaceuticals (6/14)

Bio-Rad Laboratories (8/06)

Prana Biotechnology (3/12)

Bio-Reference Laboratories (3/08)

Procter & Gamble Company (P&G) (7/19)

Cardinal Health (CAH) (5/16)

Propanc Biopharm, Inc (PPCH) (11/18)

China Medical Technologies (2/10)

ProQR Therapeutics N.V. (2/15)

DNAPrint Genomics, Inc. (5/11)

Qiagen (8/08)

Elysium Therapeutics, Inc. (6/13)

QLT Inc, Vancouver, Canada (5/10)

Galena (GALE) Biopharma, Inc. (7/13)

ReceptoPharm (12/18)

GeneDx (2/10)

Sagent Pharmaceuticals Inc. (5/14)

General Electric (GE) (5/12)

Shenzhen Mindray Biomedical Electronics (7/09)

General Electric Capital (GEH) (11/18)

Smith & Nephew (8/10)

Generex Biotechnology Crop (5/11)

Surgivision (4/06)

Given Imaging (5/06)

Symmetry Medical (4/07)

GW Pharmaceuticals (09/13)

TaiMed Biologics (12/18)

Healthpure, Inc (05/17)

Techniplast, USA (10/07)

Hospira (4/13)

Tekla Healthcare Opportunities (7/14)

Hypermarcas S.A. (3/15)

Tekmira Pharmaceuticals (8/14)

IQVIA - formerly Quintiles IMS Holdings Inc (IVQ) (12/18)

The McConnell Group (10/07)

Illumina Inc. (6/14)

TomoTherapy (7/08)

Immunotech Laboratories (IMBB) (12/18)

Transgenomic (2/12)

Isarna Therapeutics (5/14)

Trinity Biotech (10/14)

Kinetic Concepts, Inc. (6/09)

Unimicro Technologies (7/08)

Lab Products, Inc (10/07)

World Precision Instruments (10/07)

Lannett Co. Inc (LCI) (12/18)

Wuxi Pharma Tech (4/14)

Manhattan Scientifics Inc (MHTX) (03/17)

 

 

SAO Links:

Updated: 8/19/20